Here, our findings highlight ways by which a highly inflamed TME may drive the transition of peritumoral CD90+CD73+ cells into critical regulators of T effector cell function and provide a potential means of targeting this axis to boost host antitumor immunity and response to ICB in the setting of NSCLC. The gene discussed is NT5E; the disease is non-small cell lung carcinoma.